There’s nothing more disastrous for a pharmaceutical company than having to recall a batch of medication. Over the years, companies have recalled drugs for many reasons such as the presence of ...

Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...

In the highly regulated and complex life sciences industry, returns management has traditionally been seen as a necessary operational function. However, advances in technology and increasing emphasis ...

HCPs and key opinion leaders (KOLs) have always been central to the success of new therapies, shaping how innovations reach patients and influencing the trajectory of scientific understanding within ...

Caris projects 2026 total revenue in the range of $1.0 billion to $1.02 billion, anticipating molecular profiling growth of approximately 21% to 22%, and therapy selection volume growth of around 20% ...

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas ...